

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | interferon-gamma secretion (GO:0072643) | 7.25927866 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 7.12671855 |
| 3 | cell adhesion mediated by integrin (GO:0033627) | 6.80558713 |
| 4 | skin morphogenesis (GO:0043589) | 6.51739321 |
| 5 | mesodermal cell differentiation (GO:0048333) | 5.89315641 |
| 6 | regulation of alkaline phosphatase activity (GO:0010692) | 5.67144845 |
| 7 | regulation of vitamin metabolic process (GO:0030656) | 5.65266744 |
| 8 | wound healing, spreading of epidermal cells (GO:0035313) | 5.38544676 |
| 9 | low-density lipoprotein particle clearance (GO:0034383) | 5.24325868 |
| 10 | hypotonic response (GO:0006971) | 4.83123185 |
| 11 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.82742780 |
| 12 | hepatocyte apoptotic process (GO:0097284) | 4.61253212 |
| 13 | substrate-dependent cell migration (GO:0006929) | 4.58430644 |
| 14 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.50720966 |
| 15 | regulation of immunoglobulin secretion (GO:0051023) | 4.39202452 |
| 16 | regulation of podosome assembly (GO:0071801) | 4.28714797 |
| 17 | activation of MAPKKK activity (GO:0000185) | 4.18011944 |
| 18 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.15364598 |
| 19 | regulation of mononuclear cell migration (GO:0071675) | 4.11925166 |
| 20 | positive regulation of type 2 immune response (GO:0002830) | 4.10599225 |
| 21 | lung lobe morphogenesis (GO:0060463) | 4.03768060 |
| 22 | detection of bacterium (GO:0016045) | 3.98547925 |
| 23 | positive regulation of p38MAPK cascade (GO:1900745) | 3.97598904 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97407735 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.97407735 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97407735 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 3.97407735 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97407735 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97407735 |
| 30 | wound healing, spreading of cells (GO:0044319) | 3.96899509 |
| 31 | positive regulation of acute inflammatory response (GO:0002675) | 3.90107061 |
| 32 | detection of other organism (GO:0098543) | 3.88657330 |
| 33 | response to host (GO:0075136) | 3.86312483 |
| 34 | response to host defenses (GO:0052200) | 3.86312483 |
| 35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.86312483 |
| 36 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.82078168 |
| 37 | hepatocyte differentiation (GO:0070365) | 3.77726289 |
| 38 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.77221684 |
| 39 | decidualization (GO:0046697) | 3.75905772 |
| 40 | regulation of transmission of nerve impulse (GO:0051969) | 3.75093367 |
| 41 | negative regulation of lipid storage (GO:0010888) | 3.72880975 |
| 42 | positive regulation of heat generation (GO:0031652) | 3.71126174 |
| 43 | lung vasculature development (GO:0060426) | 3.68656560 |
| 44 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.67618646 |
| 45 | regulation of fever generation (GO:0031620) | 3.65723357 |
| 46 | renal filtration (GO:0097205) | 3.63796867 |
| 47 | lung epithelium development (GO:0060428) | 3.60079550 |
| 48 | hemidesmosome assembly (GO:0031581) | 3.57845831 |
| 49 | monocyte chemotaxis (GO:0002548) | 3.54781594 |
| 50 | regulation of chemokine biosynthetic process (GO:0045073) | 3.53749706 |
| 51 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.50835872 |
| 52 | defense response to protozoan (GO:0042832) | 3.48644937 |
| 53 | diterpenoid biosynthetic process (GO:0016102) | 3.47758715 |
| 54 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.44380407 |
| 55 | type I interferon signaling pathway (GO:0060337) | 3.41813711 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.41813711 |
| 57 | response to host immune response (GO:0052572) | 3.40984466 |
| 58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40984466 |
| 59 | response to type I interferon (GO:0034340) | 3.36550655 |
| 60 | establishment of endothelial barrier (GO:0061028) | 3.35201943 |
| 61 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.35136719 |
| 62 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.32459424 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 3.29416169 |
| 64 | myeloid dendritic cell differentiation (GO:0043011) | 3.28160678 |
| 65 | germinal center formation (GO:0002467) | 3.27413374 |
| 66 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.26105596 |
| 67 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.24433183 |
| 68 | regulation of type 2 immune response (GO:0002828) | 3.23707077 |
| 69 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.22332923 |
| 70 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.22016299 |
| 71 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.19030352 |
| 72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.17167197 |
| 73 | response to muramyl dipeptide (GO:0032495) | 3.16861929 |
| 74 | T-helper 1 type immune response (GO:0042088) | 3.16601152 |
| 75 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.14895062 |
| 76 | positive regulation of interleukin-6 production (GO:0032755) | 3.13936656 |
| 77 | * cellular response to lipopolysaccharide (GO:0071222) | 3.13235711 |
| 78 | adhesion of symbiont to host (GO:0044406) | 3.12852411 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 3.12516555 |
| 80 | iron coordination entity transport (GO:1901678) | 3.10397635 |
| 81 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.09224444 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 3.09043215 |
| 83 | positive regulation of smooth muscle cell proliferation (GO:0048661) | 3.08444911 |
| 84 | muscle organ morphogenesis (GO:0048644) | 3.06564106 |
| 85 | regulation of T-helper cell differentiation (GO:0045622) | 3.06289277 |
| 86 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04588199 |
| 87 | cellular response to arsenic-containing substance (GO:0071243) | 3.03990506 |
| 88 | response to protozoan (GO:0001562) | 3.03818729 |
| 89 | virion attachment to host cell (GO:0019062) | 3.03447463 |
| 90 | adhesion of symbiont to host cell (GO:0044650) | 3.03447463 |
| 91 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.00378726 |
| 92 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.00314042 |
| 93 | macrophage activation involved in immune response (GO:0002281) | 2.99769592 |
| 94 | response to peptidoglycan (GO:0032494) | 2.98680408 |
| 95 | * cellular response to molecule of bacterial origin (GO:0071219) | 2.97252357 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.97113088 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 2.95547844 |
| 98 | myeloid cell homeostasis (GO:0002262) | 2.94270159 |
| 99 | detection of external biotic stimulus (GO:0098581) | 2.93970695 |
| 100 | positive regulation of astrocyte differentiation (GO:0048711) | 2.92364902 |
| 101 | macroautophagy (GO:0016236) | 2.90543447 |
| 102 | response to manganese ion (GO:0010042) | 2.87529653 |
| 103 | positive regulation of chemokine production (GO:0032722) | 2.87458363 |
| 104 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.87133589 |
| 105 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.87084641 |
| 106 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86631030 |
| 107 | regulation of heat generation (GO:0031650) | 2.86602613 |
| 108 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.86372695 |
| 109 | positive regulation of macrophage differentiation (GO:0045651) | 2.84305539 |
| 110 | cytokine secretion (GO:0050663) | 2.84305265 |
| 111 | detection of biotic stimulus (GO:0009595) | 2.84182192 |
| 112 | lens fiber cell development (GO:0070307) | 2.81670808 |
| 113 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.80252090 |
| 114 | response to muscle activity (GO:0014850) | 2.80123983 |
| 115 | chronic inflammatory response (GO:0002544) | 2.80030734 |
| 116 | positive regulation of pseudopodium assembly (GO:0031274) | 2.79869375 |
| 117 | regulation of chronic inflammatory response (GO:0002676) | 2.79440369 |
| 118 | regulation of p38MAPK cascade (GO:1900744) | 2.79130344 |
| 119 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.78601979 |
| 120 | apoptotic process involved in morphogenesis (GO:0060561) | 2.78306579 |
| 121 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.76429607 |
| 122 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74925293 |
| 123 | respiratory tube development (GO:0030323) | 2.73913819 |
| 124 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.72518273 |
| 125 | eosinophil chemotaxis (GO:0048245) | 2.70786563 |
| 126 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.69064646 |
| 127 | positive regulation of osteoblast proliferation (GO:0033690) | 2.68867650 |
| 128 | protein localization to endosome (GO:0036010) | 2.68671676 |
| 129 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.68592041 |
| 130 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.67457894 |
| 131 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.66703190 |
| 132 | leukocyte aggregation (GO:0070486) | 2.66551028 |
| 133 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.66451390 |
| 134 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.65567063 |
| 135 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.65118117 |
| 136 | regulation of interleukin-6 production (GO:0032675) | 2.64130906 |
| 137 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.63890775 |
| 138 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63668251 |
| 139 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.63122787 |
| 140 | cellular response to nicotine (GO:0071316) | 2.62689267 |
| 141 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.62524098 |
| 142 | myeloid dendritic cell activation (GO:0001773) | 2.59941290 |
| 143 | mammary gland epithelial cell proliferation (GO:0033598) | 2.59918413 |
| 144 | detection of molecule of bacterial origin (GO:0032490) | 2.59791421 |
| 145 | cyclooxygenase pathway (GO:0019371) | 2.59481377 |
| 146 | * cellular response to biotic stimulus (GO:0071216) | 2.57922564 |
| 147 | response to vitamin D (GO:0033280) | 2.57034330 |
| 148 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.56905083 |
| 149 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.56905083 |
| 150 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.54991061 |
| 151 | positive regulation of interferon-alpha production (GO:0032727) | 2.54578807 |
| 152 | keratinocyte differentiation (GO:0030216) | 2.54566691 |
| 153 | negative regulation of amino acid transport (GO:0051956) | 2.53841817 |
| 154 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.51680231 |
| 155 | ovulation (GO:0030728) | 2.50377182 |
| 156 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.49339541 |
| 157 | negative regulation of glucose transport (GO:0010829) | 2.46993374 |
| 158 | dendritic cell differentiation (GO:0097028) | 2.46925681 |
| 159 | negative regulation of viral genome replication (GO:0045071) | 2.45937171 |
| 160 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.45882954 |
| 161 | * positive regulation of transcription factor import into nucleus (GO:0042993) | 2.42358940 |
| 162 | regulation of interleukin-12 production (GO:0032655) | 2.42050636 |
| 163 | positive regulation of leukocyte migration (GO:0002687) | 2.41942596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.87642619 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.42199321 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.41496751 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.21688134 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.86420780 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.67081319 |
| 7 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.63631820 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.49108757 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.41318270 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.29610570 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.15169232 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.77609600 |
| 13 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.49636018 |
| 14 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.39560596 |
| 15 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.39560596 |
| 16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.34398580 |
| 17 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.30080420 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.25686491 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19362332 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.19031057 |
| 21 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.18941363 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02334440 |
| 23 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.01601753 |
| 24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.95149149 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.90344965 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.89711335 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84865191 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83069746 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81341443 |
| 30 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.78372276 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.73539409 |
| 32 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67470353 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63237440 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.60749468 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60305960 |
| 36 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.60111346 |
| 37 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.59374620 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58152088 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.57098277 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56160501 |
| 41 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.54491704 |
| 42 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52829488 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52181568 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51503100 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45801176 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45261374 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44805306 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43189929 |
| 49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41926909 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40139272 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40108710 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38166159 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32701741 |
| 54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32701741 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30917342 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29247391 |
| 57 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28619461 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28488263 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28363630 |
| 60 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25139355 |
| 61 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.24706138 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23664294 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23553768 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23378792 |
| 65 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22688484 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21924476 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21555114 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21063325 |
| 69 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20095416 |
| 70 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.19737227 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18426673 |
| 72 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18155687 |
| 73 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16217324 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14390594 |
| 75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13333426 |
| 76 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12584428 |
| 77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12209315 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10973303 |
| 79 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10676525 |
| 80 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.10591771 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09891582 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09498293 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08666451 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08488893 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07615418 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07427599 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07394382 |
| 88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06113792 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05815153 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05785751 |
| 91 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04522567 |
| 92 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03067521 |
| 93 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03008742 |
| 94 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02736892 |
| 95 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02437596 |
| 96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02291502 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02266142 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01733104 |
| 99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00829177 |
| 100 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00746404 |
| 101 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00517279 |
| 102 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00059192 |
| 103 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.99002780 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97541733 |
| 105 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.96967630 |
| 106 | MAF_26560356_Chip-Seq_TH1_Human | 0.95967608 |
| 107 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.95515821 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95508955 |
| 109 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94307180 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94116015 |
| 111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93935272 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93684953 |
| 113 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93111556 |
| 114 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92204478 |
| 115 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92142557 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91625614 |
| 117 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91544102 |
| 118 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.91533712 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91466073 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91222746 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90478340 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90449004 |
| 123 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89895260 |
| 124 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89002059 |
| 125 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.88873922 |
| 126 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.88873922 |
| 127 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.88873922 |
| 128 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88653139 |
| 129 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87721803 |
| 130 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.87504710 |
| 131 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85619489 |
| 132 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85507638 |
| 133 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84980687 |
| 134 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83251266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.30113339 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.13992817 |
| 3 | MP0003724_increased_susceptibility_to | 3.28383508 |
| 4 | MP0009785_altered_susceptibility_to | 3.28214850 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.12764390 |
| 6 | MP0004947_skin_inflammation | 3.03223434 |
| 7 | MP0000537_abnormal_urethra_morphology | 2.93110542 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.81271314 |
| 9 | MP0002254_reproductive_system_inflammat | 2.79499811 |
| 10 | MP0003453_abnormal_keratinocyte_physiol | 2.64102603 |
| 11 | MP0005023_abnormal_wound_healing | 2.49988786 |
| 12 | MP0003436_decreased_susceptibility_to | 2.48499890 |
| 13 | MP0002332_abnormal_exercise_endurance | 2.38035604 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.34459119 |
| 15 | MP0000343_altered_response_to | 2.25216452 |
| 16 | MP0004510_myositis | 2.19138546 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.12925998 |
| 18 | MP0005076_abnormal_cell_differentiation | 2.12305850 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.00942989 |
| 20 | MP0005451_abnormal_body_composition | 1.97978605 |
| 21 | MP0001881_abnormal_mammary_gland | 1.93910558 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.90465829 |
| 23 | MP0005248_abnormal_Harderian_gland | 1.90413783 |
| 24 | MP0009278_abnormal_bone_marrow | 1.90188292 |
| 25 | MP0005164_abnormal_response_to | 1.86495638 |
| 26 | MP0003091_abnormal_cell_migration | 1.84628148 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.82389514 |
| 28 | MP0010678_abnormal_skin_adnexa | 1.78426229 |
| 29 | * MP0002419_abnormal_innate_immunity | 1.72979957 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.72440152 |
| 31 | MP0008004_abnormal_stomach_pH | 1.69682119 |
| 32 | MP0003448_altered_tumor_morphology | 1.67154727 |
| 33 | MP0000858_altered_metastatic_potential | 1.64655353 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.62978259 |
| 35 | MP0009840_abnormal_foam_cell | 1.62508855 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.61695595 |
| 37 | * MP0005025_abnormal_response_to | 1.60084084 |
| 38 | MP0003075_altered_response_to | 1.59537319 |
| 39 | MP0001542_abnormal_bone_strength | 1.59300266 |
| 40 | MP0005166_decreased_susceptibility_to | 1.55479742 |
| 41 | MP0000627_abnormal_mammary_gland | 1.51663042 |
| 42 | MP0003279_aneurysm | 1.51012907 |
| 43 | MP0009764_decreased_sensitivity_to | 1.49542056 |
| 44 | MP0003045_fibrosis | 1.45309411 |
| 45 | MP0006054_spinal_hemorrhage | 1.40713451 |
| 46 | MP0002796_impaired_skin_barrier | 1.34848763 |
| 47 | MP0004272_abnormal_basement_membrane | 1.32772618 |
| 48 | MP0005671_abnormal_response_to | 1.32716124 |
| 49 | MP0004883_abnormal_blood_vessel | 1.32521422 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.31445579 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.31331969 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.30906093 |
| 53 | * MP0005000_abnormal_immune_tolerance | 1.30205712 |
| 54 | MP0004858_abnormal_nervous_system | 1.29984769 |
| 55 | MP0001851_eye_inflammation | 1.28781576 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.28120223 |
| 57 | MP0000685_abnormal_immune_system | 1.26856859 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.24050958 |
| 59 | MP0003690_abnormal_glial_cell | 1.22265053 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.22237964 |
| 61 | MP0005501_abnormal_skin_physiology | 1.16375300 |
| 62 | MP0002295_abnormal_pulmonary_circulatio | 1.16344093 |
| 63 | MP0000249_abnormal_blood_vessel | 1.16251864 |
| 64 | MP0003828_pulmonary_edema | 1.16055848 |
| 65 | MP0005257_abnormal_intraocular_pressure | 1.15956918 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.14186738 |
| 67 | * MP0001216_abnormal_epidermal_layer | 1.14003211 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.13104685 |
| 69 | MP0005387_immune_system_phenotype | 1.12841557 |
| 70 | MP0001790_abnormal_immune_system | 1.12841557 |
| 71 | MP0005390_skeleton_phenotype | 1.11587939 |
| 72 | MP0002933_joint_inflammation | 1.09575015 |
| 73 | MP0001958_emphysema | 1.07797408 |
| 74 | MP0003866_abnormal_defecation | 1.07757136 |
| 75 | MP0002405_respiratory_system_inflammati | 1.06844616 |
| 76 | MP0002723_abnormal_immune_serum | 1.05379601 |
| 77 | MP0010368_abnormal_lymphatic_system | 1.04811677 |
| 78 | MP0000383_abnormal_hair_follicle | 1.04059939 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.02999192 |
| 80 | MP0003950_abnormal_plasma_membrane | 1.02726722 |
| 81 | MP0001849_ear_inflammation | 0.98252273 |
| 82 | MP0005595_abnormal_vascular_smooth | 0.95485668 |
| 83 | MP0009763_increased_sensitivity_to | 0.95386153 |
| 84 | MP0000604_amyloidosis | 0.95212819 |
| 85 | MP0002060_abnormal_skin_morphology | 0.93303623 |
| 86 | MP0008469_abnormal_protein_level | 0.92385933 |
| 87 | MP0000750_abnormal_muscle_regeneration | 0.92177192 |
| 88 | MP0001191_abnormal_skin_condition | 0.91226409 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.91037068 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.90071450 |
| 91 | MP0005165_increased_susceptibility_to | 0.88912445 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 0.88727358 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.88186718 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.87869006 |
| 95 | MP0003115_abnormal_respiratory_system | 0.87266954 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.86709425 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86491061 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.86095862 |
| 99 | MP0005310_abnormal_salivary_gland | 0.84917674 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.84304708 |
| 101 | MP0009931_abnormal_skin_appearance | 0.83539802 |
| 102 | MP0010771_integument_phenotype | 0.82206557 |
| 103 | MP0001879_abnormal_lymphatic_vessel | 0.82041018 |
| 104 | MP0001853_heart_inflammation | 0.81174746 |
| 105 | * MP0001819_abnormal_immune_cell | 0.80772339 |
| 106 | MP0008874_decreased_physiological_sensi | 0.80464221 |
| 107 | MP0001545_abnormal_hematopoietic_system | 0.80322065 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 0.80322065 |
| 109 | MP0001800_abnormal_humoral_immune | 0.79759879 |
| 110 | MP0005623_abnormal_meninges_morphology | 0.79755739 |
| 111 | * MP0002420_abnormal_adaptive_immunity | 0.79625620 |
| 112 | MP0009333_abnormal_splenocyte_physiolog | 0.79494618 |
| 113 | MP0005275_abnormal_skin_tensile | 0.76905870 |
| 114 | MP0002006_tumorigenesis | 0.76850271 |
| 115 | MP0003172_abnormal_lysosome_physiology | 0.76663877 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.76432216 |
| 117 | MP0006082_CNS_inflammation | 0.74791804 |
| 118 | MP0002098_abnormal_vibrissa_morphology | 0.74544165 |
| 119 | MP0005083_abnormal_biliary_tract | 0.74326787 |
| 120 | MP0000716_abnormal_immune_system | 0.74283101 |
| 121 | MP0003195_calcinosis | 0.74009689 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.73520492 |
| 123 | MP0008873_increased_physiological_sensi | 0.72992125 |
| 124 | MP0001663_abnormal_digestive_system | 0.71788034 |
| 125 | MP0002282_abnormal_trachea_morphology | 0.71192880 |
| 126 | MP0003795_abnormal_bone_structure | 0.70458621 |
| 127 | MP0005535_abnormal_body_temperature | 0.67192539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Interstitial pulmonary disease (HP:0006530) | 6.39213011 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.62107391 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.62107391 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.62107391 |
| 5 | Micronodular cirrhosis (HP:0001413) | 4.83594631 |
| 6 | Tetraparesis (HP:0002273) | 4.18657021 |
| 7 | Onycholysis (HP:0001806) | 4.15336947 |
| 8 | Orchitis (HP:0100796) | 4.04275264 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.95034419 |
| 10 | Stomatitis (HP:0010280) | 3.84786491 |
| 11 | Atrophic scars (HP:0001075) | 3.74770511 |
| 12 | Optic neuritis (HP:0100653) | 3.70912519 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.70912519 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.69345187 |
| 15 | Arterial tortuosity (HP:0005116) | 3.69098249 |
| 16 | Esophageal varix (HP:0002040) | 3.64909160 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.57098058 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.56133719 |
| 19 | Loss of speech (HP:0002371) | 3.55937172 |
| 20 | Milia (HP:0001056) | 3.55602233 |
| 21 | Abnormality of proline metabolism (HP:0010907) | 3.44875983 |
| 22 | Hydroxyprolinuria (HP:0003080) | 3.44875983 |
| 23 | Myositis (HP:0100614) | 3.42966187 |
| 24 | Pustule (HP:0200039) | 3.42023614 |
| 25 | Nuclear cataract (HP:0100018) | 3.38817814 |
| 26 | Bronchomalacia (HP:0002780) | 3.36191932 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.35809256 |
| 28 | Vascular tortuosity (HP:0004948) | 3.30516937 |
| 29 | Focal segmental glomerulosclerosis (HP:0000097) | 3.25207008 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 3.24708074 |
| 31 | Subacute progressive viral hepatitis (HP:0006572) | 3.21515472 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.12224557 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.11171282 |
| 34 | Amyloidosis (HP:0011034) | 3.03583669 |
| 35 | Fused cervical vertebrae (HP:0002949) | 3.01540384 |
| 36 | Thin bony cortex (HP:0002753) | 3.01020129 |
| 37 | Disinhibition (HP:0000734) | 3.00368715 |
| 38 | Fragile nails (HP:0001808) | 2.99161146 |
| 39 | Vertebral compression fractures (HP:0002953) | 2.96177621 |
| 40 | Axonal loss (HP:0003447) | 2.88072175 |
| 41 | Peritonitis (HP:0002586) | 2.87700186 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.84902837 |
| 43 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.84902837 |
| 44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.84902837 |
| 45 | Nail dystrophy (HP:0008404) | 2.82194313 |
| 46 | Glomerulonephritis (HP:0000099) | 2.81803706 |
| 47 | Glomerulosclerosis (HP:0000096) | 2.78924925 |
| 48 | Bowing of the arm (HP:0006488) | 2.77973027 |
| 49 | Bowed forearm bones (HP:0003956) | 2.77973027 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.77766512 |
| 51 | Short nail (HP:0001799) | 2.73536982 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.73153683 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73153683 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.73032083 |
| 55 | Premature rupture of membranes (HP:0001788) | 2.70408728 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.67642641 |
| 57 | Ankyloglossia (HP:0010296) | 2.64066893 |
| 58 | Hematochezia (HP:0002573) | 2.58945749 |
| 59 | Aortic aneurysm (HP:0004942) | 2.58847856 |
| 60 | Thoracolumbar scoliosis (HP:0002944) | 2.55958790 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.54569413 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.53088648 |
| 63 | Follicular hyperkeratosis (HP:0007502) | 2.52487553 |
| 64 | Radial bowing (HP:0002986) | 2.49924447 |
| 65 | Abnormality of the nasal septum (HP:0000419) | 2.47927535 |
| 66 | Choroideremia (HP:0001139) | 2.47156856 |
| 67 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46930095 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.41617610 |
| 69 | Episodic fever (HP:0001954) | 2.40678057 |
| 70 | Ulnar bowing (HP:0003031) | 2.40622149 |
| 71 | Myocardial infarction (HP:0001658) | 2.40009428 |
| 72 | Achilles tendon contracture (HP:0001771) | 2.37274498 |
| 73 | Mutism (HP:0002300) | 2.36225239 |
| 74 | Apathy (HP:0000741) | 2.33956179 |
| 75 | Cerebral aneurysm (HP:0004944) | 2.33109860 |
| 76 | Plantar hyperkeratosis (HP:0007556) | 2.32792346 |
| 77 | Synostosis involving the elbow (HP:0003938) | 2.29653141 |
| 78 | Humeroradial synostosis (HP:0003041) | 2.29653141 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29293582 |
| 80 | Cervical subluxation (HP:0003308) | 2.28256487 |
| 81 | Protrusio acetabuli (HP:0003179) | 2.27860143 |
| 82 | Xerostomia (HP:0000217) | 2.27567305 |
| 83 | Shallow orbits (HP:0000586) | 2.27027086 |
| 84 | Anorexia (HP:0002039) | 2.26527267 |
| 85 | Colitis (HP:0002583) | 2.25607075 |
| 86 | Recurrent bacterial skin infections (HP:0005406) | 2.23924056 |
| 87 | Metaphyseal irregularity (HP:0003025) | 2.23572848 |
| 88 | Menorrhagia (HP:0000132) | 2.23302131 |
| 89 | Hemorrhage of the eye (HP:0011885) | 2.22493409 |
| 90 | Complement deficiency (HP:0004431) | 2.22203549 |
| 91 | Increased serum ferritin (HP:0003281) | 2.21420277 |
| 92 | Malnutrition (HP:0004395) | 2.20621929 |
| 93 | Anhidrosis (HP:0000970) | 2.20197873 |
| 94 | Diminished motivation (HP:0000745) | 2.19366978 |
| 95 | Ankle contracture (HP:0006466) | 2.19354098 |
| 96 | Alopecia of scalp (HP:0002293) | 2.17938632 |
| 97 | Pili torti (HP:0003777) | 2.17865697 |
| 98 | Abnormal blistering of the skin (HP:0008066) | 2.15881119 |
| 99 | Hypoplasia of dental enamel (HP:0006297) | 2.14622194 |
| 100 | Stenosis of the external auditory canal (HP:0000402) | 2.12996382 |
| 101 | Type 1 muscle fiber predominance (HP:0003803) | 2.12924574 |
| 102 | Curly hair (HP:0002212) | 2.12255240 |
| 103 | Keratoconjunctivitis (HP:0001096) | 2.11492779 |
| 104 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.10163416 |
| 105 | Hyperparathyroidism (HP:0000843) | 2.09173608 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 2.08513041 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.08388932 |
| 108 | Aortic dissection (HP:0002647) | 2.08328293 |
| 109 | Aneurysm (HP:0002617) | 2.06347562 |
| 110 | Hemoptysis (HP:0002105) | 2.06344103 |
| 111 | Abnormality of the Achilles tendon (HP:0005109) | 2.06159116 |
| 112 | Genu recurvatum (HP:0002816) | 2.06068131 |
| 113 | Abnormality of complement system (HP:0005339) | 2.05185982 |
| 114 | Abnormality of oral frenula (HP:0000190) | 2.04275939 |
| 115 | Gangrene (HP:0100758) | 2.03067623 |
| 116 | Spondylolisthesis (HP:0003302) | 2.02554232 |
| 117 | Increased mean platelet volume (HP:0011877) | 2.00747197 |
| 118 | Increased IgM level (HP:0003496) | 2.00666572 |
| 119 | Arterial thrombosis (HP:0004420) | 1.97673925 |
| 120 | Striae distensae (HP:0001065) | 1.97672657 |
| 121 | Upper motor neuron abnormality (HP:0002127) | 1.97516101 |
| 122 | Abnormality of the common coagulation pathway (HP:0010990) | 1.97057249 |
| 123 | Slender build (HP:0001533) | 1.96503791 |
| 124 | Deep venous thrombosis (HP:0002625) | 1.96104125 |
| 125 | Urticaria (HP:0001025) | 1.95503104 |
| 126 | Abnormality of the pericardium (HP:0001697) | 1.95048926 |
| 127 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.94361166 |
| 128 | Progressive neurologic deterioration (HP:0002344) | 1.93743043 |
| 129 | Nephritis (HP:0000123) | 1.92423835 |
| 130 | Joint swelling (HP:0001386) | 1.92158629 |
| 131 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91650904 |
| 132 | Nausea (HP:0002018) | 1.91499852 |
| 133 | Basal ganglia calcification (HP:0002135) | 1.90665028 |
| 134 | Abnormality of the pleura (HP:0002103) | 1.90570320 |
| 135 | Bone pain (HP:0002653) | 1.90389552 |
| 136 | Rectal prolapse (HP:0002035) | 1.89066071 |
| 137 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.88208628 |
| 138 | Obstructive lung disease (HP:0006536) | 1.86563744 |
| 139 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86563744 |
| 140 | Fragile skin (HP:0001030) | 1.86298975 |
| 141 | Gingivitis (HP:0000230) | 1.83332938 |
| 142 | Hypergammaglobulinemia (HP:0010702) | 1.82730935 |
| 143 | Oligomenorrhea (HP:0000876) | 1.81969129 |
| 144 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.81577201 |
| 145 | Osteolytic defects of the hand bones (HP:0009699) | 1.81577201 |
| 146 | Parakeratosis (HP:0001036) | 1.81397512 |
| 147 | Abdominal distention (HP:0003270) | 1.80419594 |
| 148 | Premature loss of primary teeth (HP:0006323) | 1.80251038 |
| 149 | Increased density of long bones (HP:0006392) | 1.79898022 |
| 150 | Femoral bowing (HP:0002980) | 1.79758786 |
| 151 | Glomerulopathy (HP:0100820) | 1.78744556 |
| 152 | Inflammation of the large intestine (HP:0002037) | 1.78656385 |
| 153 | Emphysema (HP:0002097) | 1.78588443 |
| 154 | Pulmonary infiltrates (HP:0002113) | 1.78309554 |
| 155 | Spinal rigidity (HP:0003306) | 1.77015605 |
| 156 | Vasculitis (HP:0002633) | 1.74984674 |
| 157 | Thick nail (HP:0001805) | 1.74122750 |
| 158 | Progressive hearing impairment (HP:0001730) | 1.74029258 |
| 159 | Abnormality of the nasal mucosa (HP:0000433) | 1.72569829 |
| 160 | Abnormal platelet volume (HP:0011876) | 1.70551700 |
| 161 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.70381023 |
| 162 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70305859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK2 | 3.21133262 |
| 2 | NME2 | 3.21104095 |
| 3 | MAP3K14 | 2.73006986 |
| 4 | MOS | 2.63144130 |
| 5 | TBK1 | 2.59798803 |
| 6 | MST4 | 2.57033808 |
| 7 | GRK7 | 2.57005835 |
| 8 | EPHB1 | 2.50511798 |
| 9 | EPHA2 | 12.0056166 |
| 10 | PRPF4B | 1.99653884 |
| 11 | MST1R | 1.99610451 |
| 12 | PTK2 | 1.80815019 |
| 13 | RPS6KB2 | 1.71903448 |
| 14 | CDC42BPA | 1.65282271 |
| 15 | RIPK1 | 1.61466194 |
| 16 | PTK6 | 1.54193035 |
| 17 | BMPR2 | 1.49412820 |
| 18 | IRAK3 | 1.47756702 |
| 19 | MAP3K3 | 1.45644311 |
| 20 | PAK4 | 1.44149147 |
| 21 | ADRBK2 | 1.41019255 |
| 22 | IKBKE | 1.39027996 |
| 23 | ARAF | 1.36151280 |
| 24 | STK10 | 1.35484675 |
| 25 | TGFBR2 | 1.32159071 |
| 26 | BMX | 1.31318531 |
| 27 | FGFR4 | 1.30500012 |
| 28 | CHUK | 1.28588238 |
| 29 | NEK9 | 1.25604194 |
| 30 | LRRK2 | 1.25458198 |
| 31 | EPHB2 | 1.25163520 |
| 32 | IKBKB | 1.24986864 |
| 33 | MAP3K9 | 1.21233422 |
| 34 | ERBB4 | 1.18353492 |
| 35 | CSK | 1.17972586 |
| 36 | ERN1 | 1.17697529 |
| 37 | BLK | 1.17550904 |
| 38 | FER | 1.15880050 |
| 39 | IRAK2 | 1.08697734 |
| 40 | TRIB3 | 1.07935311 |
| 41 | IRAK1 | 1.07266608 |
| 42 | DMPK | 1.02089455 |
| 43 | MAP3K5 | 0.97553222 |
| 44 | PRKG2 | 0.95559827 |
| 45 | TESK1 | 0.95268104 |
| 46 | LATS1 | 0.89388910 |
| 47 | MAP2K2 | 0.89341266 |
| 48 | MAP3K1 | 0.89151738 |
| 49 | PKN2 | 0.87430454 |
| 50 | MET | 0.86637045 |
| 51 | EPHA3 | 0.80952611 |
| 52 | KSR2 | 0.79394055 |
| 53 | MAP2K1 | 0.78695530 |
| 54 | FGR | 0.78629847 |
| 55 | TYK2 | 0.78250683 |
| 56 | PBK | 0.76957289 |
| 57 | TXK | 0.75997640 |
| 58 | MAP4K1 | 0.73444553 |
| 59 | RPS6KA4 | 0.71192670 |
| 60 | MAP3K2 | 0.70087408 |
| 61 | LATS2 | 0.68878853 |
| 62 | MAP3K12 | 0.66427308 |
| 63 | EGFR | 0.65891093 |
| 64 | TGFBR1 | 0.62940230 |
| 65 | TTN | 0.62394105 |
| 66 | DDR2 | 0.62313094 |
| 67 | PAK3 | 0.62269016 |
| 68 | PIM2 | 0.61876998 |
| 69 | ALK | 0.61540237 |
| 70 | TAOK1 | 0.60186326 |
| 71 | MAP3K11 | 0.58138853 |
| 72 | TRPM7 | 0.57466507 |
| 73 | ABL2 | 0.57000788 |
| 74 | PDGFRA | 0.56110442 |
| 75 | BCR | 0.56072686 |
| 76 | SIK1 | 0.55785278 |
| 77 | FLT3 | 0.55425685 |
| 78 | TYRO3 | 0.54903001 |
| 79 | SIK3 | 0.53804026 |
| 80 | FRK | 0.53663697 |
| 81 | DYRK3 | 0.53327193 |
| 82 | MAP3K10 | 0.53145904 |
| 83 | GRK5 | 0.51069093 |
| 84 | PTK2B | 0.50568486 |
| 85 | CDK8 | 0.47347020 |
| 86 | LYN | 0.46436834 |
| 87 | GSK3A | 0.44470319 |
| 88 | ABL1 | 0.44373508 |
| 89 | JAK1 | 0.44270404 |
| 90 | CAMK2B | 0.43931141 |
| 91 | CDK6 | 0.43599641 |
| 92 | BRAF | 0.42714535 |
| 93 | INSR | 0.42186060 |
| 94 | HIPK2 | 0.41685064 |
| 95 | JAK2 | 0.40143360 |
| 96 | MAPKAPK2 | 0.39325262 |
| 97 | NTRK1 | 0.39166062 |
| 98 | MATK | 0.38525822 |
| 99 | PDGFRB | 0.36740335 |
| 100 | MAP2K3 | 0.36226972 |
| 101 | MAPK7 | 0.35829994 |
| 102 | ERBB3 | 0.35655309 |
| 103 | LCK | 0.34578201 |
| 104 | IRAK4 | 0.34032591 |
| 105 | RPS6KC1 | 0.34009418 |
| 106 | RPS6KL1 | 0.34009418 |
| 107 | CAMK2G | 0.32980935 |
| 108 | JAK3 | 0.32438349 |
| 109 | RIPK4 | 0.31848910 |
| 110 | MARK3 | 0.31318201 |
| 111 | RPS6KA2 | 0.30504962 |
| 112 | LIMK1 | 0.30125773 |
| 113 | PKN1 | 0.30113193 |
| 114 | CAMK2D | 0.29935846 |
| 115 | MAP3K13 | 0.29298764 |
| 116 | ZAP70 | 0.28579436 |
| 117 | PDPK1 | 0.28539644 |
| 118 | ICK | 0.28199803 |
| 119 | SRC | 0.27924847 |
| 120 | HCK | 0.27912553 |
| 121 | MAP3K7 | 0.27818784 |
| 122 | MAP3K8 | 0.27501079 |
| 123 | SYK | 0.26404778 |
| 124 | PIM1 | 0.25716100 |
| 125 | STK3 | 0.25573518 |
| 126 | PRKD2 | 0.25376853 |
| 127 | KIT | 0.25329718 |
| 128 | MELK | 0.25068289 |
| 129 | MAPK4 | 0.25013414 |
| 130 | STK24 | 0.24795545 |
| 131 | CSNK1A1L | 0.24629224 |
| 132 | PAK2 | 0.24281647 |
| 133 | DAPK3 | 0.23933601 |
| 134 | PRKCE | 0.23848453 |
| 135 | RAF1 | 0.23450131 |
| 136 | RPS6KA6 | 0.22504465 |
| 137 | CSF1R | 0.22370917 |
| 138 | CLK1 | 0.22292963 |
| 139 | PRKCD | 0.20939202 |
| 140 | MAP2K6 | 0.20595511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.91590926 |
| 2 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.73660682 |
| 3 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.62868092 |
| 4 | * Malaria_Homo sapiens_hsa05144 | 2.41726152 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.39499387 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.25944388 |
| 7 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.23169777 |
| 8 | Prion diseases_Homo sapiens_hsa05020 | 2.13337069 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12199825 |
| 10 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.01749218 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95737678 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.94549345 |
| 13 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.92313959 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.91419194 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89938967 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86250375 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.82490255 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.79988437 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.79262206 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.78135590 |
| 21 | Amoebiasis_Homo sapiens_hsa05146 | 1.75467156 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.74006569 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.68204452 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.64639901 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.60077527 |
| 26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.59101375 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.58096934 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.57741750 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51024408 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.49143248 |
| 31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.46557236 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.40876276 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.39426938 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38592150 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38364583 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.38209029 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.36816458 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29913553 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.26934764 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26790499 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.24894456 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.24596352 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21306708 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.21067944 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19248102 |
| 46 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11731763 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11467530 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.10290230 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09634596 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.07450590 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06555005 |
| 52 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05835591 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04950286 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04928866 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 1.03911213 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03172182 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.02318308 |
| 58 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98740482 |
| 59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96564699 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96471790 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.93784929 |
| 62 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92073926 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89729622 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87961656 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87594902 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86651827 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86538193 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84197332 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83799880 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.83798421 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.80630701 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79443754 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.69711733 |
| 74 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69210069 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.68858399 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67343354 |
| 77 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67221831 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66924586 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66452433 |
| 80 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65569847 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65433601 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62992714 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62700319 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62619527 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60389212 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59533352 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57942685 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57763143 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.57419605 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55020221 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53886416 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53693248 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53399803 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49783033 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49457305 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.49320672 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48690231 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47561048 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47088001 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46406057 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45388560 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44944256 |
| 103 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44741208 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43943260 |
| 105 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43922180 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43648768 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43556956 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42689407 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42298065 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40070808 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39684850 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38456193 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.38454088 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38394483 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38323855 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37196326 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36739423 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35829181 |
| 119 | Melanoma_Homo sapiens_hsa05218 | 0.34574482 |
| 120 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.30055938 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25583137 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22788130 |

